Skip to main content

Peer Review reports

From: Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer—is there a “tail plateau” in the survival curve of these patients?

Original Submission
18 Oct 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
17 Jan 2022 Reviewed Reviewer Report
19 Jan 2022 Reviewed Reviewer Report
7 Feb 2022 Author responded Author comments - Takehito Shukuya
Resubmission - Version 4
7 Feb 2022 Submitted Manuscript version 4
16 Feb 2022 Author responded Author comments - Takehito Shukuya
Resubmission - Version 5
16 Feb 2022 Submitted Manuscript version 5
21 Feb 2022 Author responded Author comments - Takehito Shukuya
Resubmission - Version 6
21 Feb 2022 Submitted Manuscript version 6
1 Mar 2022 Reviewed Reviewer Report
8 Mar 2022 Reviewed Reviewer Report
14 Mar 2022 Author responded Author comments - Takehito Shukuya
Resubmission - Version 7
14 Mar 2022 Submitted Manuscript version 7
Publishing
16 Mar 2022 Editorially accepted
25 Mar 2022 Article published 10.1186/s12885-022-09421-7

You can find further information about peer review here.

Back to article page